Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study

Open access

Abstract

Objective: To determine the effect of opioid and stimulant Risk Mitigation Guidance (RMG) dispensations on mortality and acute care visits during the dual public health emergencies of overdose and covid-19. Design: Population based retrospective cohort study. Setting: British Columbia, Canada. Participants: 5882 people with opioid or stimulant use disorder who received RMG prescriptions for opioids (n=5356) and/or stimulants (n=1061) (535 received both) from 27 March 2020 to 31 August 2021. Main outcome measures: All cause and overdose specific mortality and acute care visits in the week after RMG opioid or stimulant dispensation. RMG recipients were matched 1:1 with controls through use of high dimensional propensity score matching. Marginal structural models, executed on weekly time steps, were used to measure the effect of dispensations on outcomes. Results: RMG opioid dispensations of one day or more were associated with reduced all cause mortality (adjusted hazard ratio 0.39, 95% confidence interval 0.25 to 0.60) and overdose related mortality (0.45, 0.27 to 0.75) in the subsequent week. Dispensations of RMG stimulants (≥1 days) were not significantly associated with reduced all cause mortality (adjusted hazard ratio 0.50, 0.20 to 1.23) or overdose related mortality (0.53, 0.18 to 1.56). The protective effect of RMG opioid dispensations increased with the number of days the medications were dispensed in a given week. People who received four or more days of RMG opioid dispensations had reduced all cause mortality (adjusted hazard ratio 0.09, 0.04 to 0.21) and overdose related mortality (0.11, 0.04 to 0.32) compared with the control group. Opioid RMG dispensations did not significantly modify the odds of all cause or overdose related acute care visits. Dispensations of RMG stimulants were associated with a significant decrease in the odds of acute care visits for any cause but did not affect the odds of overdose related acute care visits. Conclusions: RMG opioid dispensations were associated with reduced overdose related and all cause mortality among a sample of people with opioid use disorder. Pharmaceutical alternatives to the illegal drug supply are promising interventions to reduce mortality in people with opioid use disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj-2023-076336

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Crude event rates stratified by receipt of Risk Mitigation Guidance (RMG) opioid medications. hdPS=high dimensional propensity score; PS=propensity score
Fig 1 Crude event rates stratified by receipt of Risk Mitigation Guidance (RMG) opioid medications. hdPS=high dimensional propensity score; PS=propensity scoreCC-BY-NC · From the PDF
Fig 2 Crude event rates stratified by receipt of Risk Mitigation Guidance (RMG) stimulant medications. hdPS=high dimensional propensity score; PS=propensity score
Fig 2 Crude event rates stratified by receipt of Risk Mitigation Guidance (RMG) stimulant medications. hdPS=high dimensional propensity score; PS=propensity scoreCC-BY-NC · From the PDF
Fig 3 Results of marginal structural models on mortality. Hazard ratios are plotted on log scale. hdPS=high dimension propensity score matching; OAT=opioid agonist treatment; RMG= Risk Mitigation Guidance
Fig 3 Results of marginal structural models on mortality. Hazard ratios are plotted on log scale. hdPS=high dimension propensity score matching; OAT=opioid agonist treatment; RMG= Risk Mitigation GuidanceCC-BY-NC · From the PDF
Fig 4 Results of marginal structural models on acute healthcare visits. hdPS=high dimension propensity score matching; OAT=opioid agonist treatment; RMG= Risk Mitigation Guidance
Fig 4 Results of marginal structural models on acute healthcare visits. hdPS=high dimension propensity score matching; OAT=opioid agonist treatment; RMG= Risk Mitigation GuidanceCC-BY-NC · From the PDF
Fig 5 Sensitivity analyses: primary and secondary outcomes by weekly dose dispensed. Hazard ratios are plotted on log scale. DEX=dextroamphetamine; hdPS=high dimension propensity score matching; ME=morphine equivalent; MPH=methylphenidate; OAT=opioid agonist treatment; PS=propensity score; RMG= Risk Mitigation Guidance
Fig 5 Sensitivity analyses: primary and secondary outcomes by weekly dose dispensed. Hazard ratios are plotted on log scale. DEX=dextroamphetamine; hdPS=high dimension propensity score matching; ME=morphine equivalent; MPH=methylphenidate; OAT=opioid agonist treatment; PS=propensity score; RMG= Risk Mitigation GuidanceCC-BY-NC · From the PDF
Fig 6 Sensitivity analyses: primary and secondary outcomes by weekly dose dispensed. DEX=dextroamphetamine; hdPS=high dimension propensity score matching; ME=morphine equivalent; MPH=methylphenidate; OAT=opioid agonist treatment; PS=propensity score; RMG= Risk Mitigation Guidance
Fig 6 Sensitivity analyses: primary and secondary outcomes by weekly dose dispensed. DEX=dextroamphetamine; hdPS=high dimension propensity score matching; ME=morphine equivalent; MPH=methylphenidate; OAT=opioid agonist treatment; PS=propensity score; RMG= Risk Mitigation GuidanceCC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 100

Metadata

Authors
Slaunwhite, A., Min, J. E., Palis, H., Urbanoski, K., Pauly, B., Barker, B., Crabtree, A., Bach, P., Krebs, E., Dale, L., Meilleur, L., & Nosyk, B.
Affiliations
  • University of British Columbia (CA)
  • Centre for Advancing Health Outcomes (CA)
  • University of Victoria (CA)
  • Simon Fraser University (CA)
  • BC Cancer Agency (CA)
  • First Nations Health Authority (CA)
Corresponding author
Nosyk, Bohdan
Venue
BMJ
Publisher
BMJ
Published
2024-01-10
Volume
384
Pages
e076336
ISSN
1756-1833 (ISSN-L)
OpenAlex
W4390718539
Cited by
100
References
40
Citations by year
2026: 17 · 2025: 43 · 2024: 40
FWCI
41.42
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • UVic’s Research and Learning Repository (University of Victoria) (submittedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
opioid use disorder, stimulant use disorder, drug overdose deaths, all-cause mortality, acute care visits, COVID-19 pandemic, public health emergencies, harm reduction, British Columbia
MeSH terms
Central Nervous System Stimulants, Analgesics, Opioid, British Columbia, Emergencies, Humans, Opioid-Related Disorders, Public Health, Retrospective Studies, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. https://app.cochat.ai/papers/10.1136/bmj-2023-076336
The paper
Slaunwhite, A., Min, J. E., Palis, H., Urbanoski, K., Pauly, B., Barker, B., Crabtree, A., Bach, P., Krebs, E., Dale, L., Meilleur, L., & Nosyk, B. (2024). Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ. https://doi.org/10.1136/bmj-2023-076336

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.